StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Evercore ISI Upgrades Vertex (VRTX) to Outperform
April 11, 2024 6:01 AM
Evercore ISI analyst Liisa Bayko upgraded Vertex (NASDAQ: VRTX) from In Line to Outperform with a price target of $438.00.The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Comments
Hot Upgrades
Upgrades
Next Articles
Vertex Pharma (VRTX) April 430 and 440 puts active
April 11, 2024 4:39 AM
US stock futures fall after hot inflation dashes rate cut hopes
April 11, 2024 3:45 AM
After-hours movers: Alpine Immune Sciences, Costco, and more
April 10, 2024 4:57 PM
Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal
April 10, 2024 4:19 PM
Vertex (VRTX) Enters Into Agreement to Acquire Alpine Immune Sciences (ALPN)
April 10, 2024 4:02 PM
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
April 10, 2024 4:01 PM
Form SC 13G/A VERTEX PHARMACEUTICALS Filed by: Capital World Investors
April 10, 2024 12:14 PM
Vertex to Announce First Quarter 2024 Financial Results on May 6
April 9, 2024 4:05 PM
Vortex Energy Announces Drilling Update and $115,500 Grant Award At The Robinsons River Salt Project
April 9, 2024 8:00 AM
